In this study, we analyzed the frequencies of circulating MDSCs, their inhibiting capacity on IFN-γ production in T-cells, and their expression of Arg-1 in patients with MG before and after immunotherapy, trying to find the functional alterations of MDSC in MG during different disease stages. The gene discussed is ARG1; the disease is myasthenia gravis.